Patent · US Expired

β2 andrenergic polymorphism detection

US7211381B1 · kind B1 · utility

0Cited by
11References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 4, 2000
Grant dateMay 1, 2007
Priority date
Expiry dateApr 4, 2020

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/81
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Nucleic acid sequences are provided that are useful as amplification primers and hybridization probes for amplifying and detecting target sequence from the β2 adrenergic receptor gene. The primers and probes can be employed in amplification based methods for detecting the presence of the target sequence in a test sample.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.